Editas Medicine, Inc.
EDIT
$2.35
-$0.11-4.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 77.62% | 52.82% | 30.03% | -67.61% | 26.95% |
| Total Depreciation and Amortization | 11.65% | -60.69% | -4.33% | -39.55% | 1,760.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -64.07% | -21.42% | -33.66% | 145.91% | -34.12% |
| Change in Net Operating Assets | -201.60% | -138.35% | -126.23% | 245.59% | -378.84% |
| Cash from Operations | -17.97% | 38.57% | -5.05% | 5.84% | 3.47% |
| Capital Expenditure | 86.14% | -- | 100.00% | 78.89% | 81.51% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -5.87% | -24.78% | 79.38% | -63.75% |
| Cash from Investing | -99.85% | -7.21% | -24.36% | 82.14% | -63.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.91% | 131.64% | 416.52% | 433.46% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -105.20% | -- |
| Cash from Financing | 0.91% | 131.64% | 615.80% | -102.59% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -173.37% | 17,366.00% | -102.10% | -79.97% | 13.76% |